SIOPE/Facebook
Apr 25, 2025, 15:26
SIOP Europe and CCI-E joint position for the revision of the EU pharmaceutical legislation
SIOP Europe shared a post on Facebook:
“Unlocking new possibilities with what we already have.
Did you know that many existing drugs could be repurposed for childhood cancer treatment? But academic research struggles to make these medicines available due to regulatory and industry barriers.
We advocate for academic-led drug repurposing to be recognised and supported in the EU Pharma package to ensure lifesaving medicines reach children in need.
What can you do? Engage with us:
Share these posts to amplify our message
Use EUPharma4Children, EUPharmaAdvocacy Series, and Childhood Cancer to join the conversation
Visit our dedicated webpage.”
More posts featuring SIOP Europe
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 24, 2025, 07:13
Aug 24, 2025, 04:55
Aug 24, 2025, 01:32
Aug 23, 2025, 22:57
Aug 23, 2025, 22:35